US2021268058A1PendingUtilityA1

Neem for treatment of rls

Assignee: VORDERWUELBECKE MARTINPriority: Jun 26, 2018Filed: Jun 19, 2019Published: Sep 2, 2021
Est. expiryJun 26, 2038(~11.9 yrs left)· nominal 20-yr term from priority
A61K 36/58A61P 25/14A61K 31/58A61K 45/06A61K 2236/15A61K 9/0014A61K 31/343A61K 31/352
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical product of the present invention contains plant parts obtained from the neem tree Azadirachta indica or active ingredients derived from such plant parts for use in treating, preventing and/or alleviating symptoms of restless legs syndrome.

Claims

exact text as granted — not AI-modified
1 . Pharmaceutical product containing plant parts obtained from the neem tree  Azadirachta indica  or active ingredients derived from such plant parts for use in treating, preventing and/or alleviating symptoms of restless legs syndrome (RLS). 
     
     
         2 . Pharmaceutical product for the use according to  claim 1 , wherein the plant parts are derived from leaves, flowers, seed, gum, fruit or bark of the neem tree. 
     
     
         3 . Pharmaceutical product for use according to  claim 1 , comprising crushed or shredded neem tree leaves. 
     
     
         4 . Pharmaceutical product for use according to  claim 1 , wherein active ingredients are obtained by extraction and can be included as crude or complex mixture of substances or as partly or fully isolated substances. 
     
     
         5 . Pharmaceutical product for use according to  claim 4 , wherein the active ingredients include at least one of nimbin, nimbinin, nimbidin, salannin, meliantriol and azadirachtin. 
     
     
         6 . Pharmaceutical product for use according to  claim 1 , which is provided in a form suitable for internal use. 
     
     
         7 . Pharmaceutical product for use according to  claim 6 , in dry or liquid form, especially a powder, granules, pills, tablets, lozenges, capsules or an emulsion, a suspension, an extract, an oil, a tea or tea preparation. 
     
     
         8 . Pharmaceutical product for use according to  claim 1 , further containing additional pharmaceutically active substances or drugs, preferably analgesic and/or antiphlogistic substances. 
     
     
         9 . Pharmaceutical product for use according to  claim 1 , further comprising substances selected from pharmaceutically acceptable adjuvants and excipients, especially fillers, lubricants, glidants, binders, compounds which ensure easy disintegration, disaggregation and dissolution of a tablet in the stomach or the intestine, compounds providing for sustained release, sweeteners, sugar, varnish or wax, flavor, coloring agents or preservatives. 
     
     
         10 . Pharmaceutical product for use according to  claim 1 , comprising oil obtained from neem seeds. 
     
     
         11 . Pharmaceutical product for use according to  claim 1 , which is provided in a form suitable for external use. 
     
     
         12 . Pharmaceutical product for use according to  claim 11 , which is provided in the form of a paste, cream, balm, ointment, emulsion, suspension, gel, spray or foam. 
     
     
         13 . Pharmaceutical product for use according to  claim 11 , which is capable of penetrating the skin and/or being absorbed into the blood circulation. 
     
     
         14 . Pharmaceutical product for use according to  claim 11 , further comprising additional pharmaceutically active substances or drugs, preferably analgesic and/or antiphlogistic substances. 
     
     
         15 . Pharmaceutical product for use according to  claim 11 , further comprising substances selected from pharmaceutically acceptable adjuvants, excipients and preservatives.

Join the waitlist — get patent alerts

Track US2021268058A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.